Bahrain authorizes use of Pfizer’s anti-COVID drug -state news agency


CAIRO – Bahrain’s health authorities authorized Pfizer’s Paxlovid COVID-19 drug for emergency use in adults aged over 18, the state news agency said in a statement on Saturday.

The decision by the National Authority for Regulating Health Professions and Services was based on the review and evaluation of data provided by Pfizer, the statement added.


You may also like

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: